165 related articles for article (PubMed ID: 20575664)
81. Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics.
Canini L; Carrat F
J Virol; 2011 Mar; 85(6):2764-70. PubMed ID: 21191031
[TBL] [Abstract][Full Text] [Related]
82. [Review on the etiological property of 1977 Russian flu virus (H1N1)].
Zhou JF; Yang L; Lan Y; Li Z; Zhao X; Wang M; Guo YJ; Li DX; Shu YL
Bing Du Xue Bao; 2009 May; 25 Suppl():21-2. PubMed ID: 20361595
[No Abstract] [Full Text] [Related]
83. Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study.
Sloan SE; Szretter KJ; Sundaresh B; Narayan KM; Smith PF; Skurnik D; Bedard S; Trevejo JM; Oldach D; Shriver Z
Antiviral Res; 2020 Dec; 184():104763. PubMed ID: 32151645
[TBL] [Abstract][Full Text] [Related]
84. Skin rash in a patient with A(H1N1) infection.
Huber LC; Kamarachev J; Maggiorini M; Müller V
Intensive Care Med; 2010 Oct; 36(10):1793-1794. PubMed ID: 20631984
[No Abstract] [Full Text] [Related]
85. Role of cytokines and chemokines in severe and complicated influenza infections.
Lee NL
Hong Kong Med J; 2009 Dec; 15 Suppl 8():38-41. PubMed ID: 20393212
[No Abstract] [Full Text] [Related]
86. Pandemic (H1N1) 2009 and HIV co-infection.
Barchi E; Prati F; Parmeggiani M; Tanzi ML
Emerg Infect Dis; 2010 Oct; 16(10):1643-4. PubMed ID: 20875304
[No Abstract] [Full Text] [Related]
87. Detection of pandemic influenza-A(H1N1)-2009 virus in urine.
Ho YL; Yoshino A; Tonacio AC; Latif AZ; Caiaffa Filho HH; De Sousa dos Santos S
Intensive Care Med; 2013 Jun; 39(6):1168-9. PubMed ID: 23604135
[No Abstract] [Full Text] [Related]
88. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation.
Chan JF; To KK; Tse H; Lau CC; Li IW; Hung IF; Chan KH; Cheng VC; Lai TS; Woo PC; Chan EY; Yuen KY
Clin Vaccine Immunol; 2011 Feb; 18(2):305-10. PubMed ID: 21123524
[TBL] [Abstract][Full Text] [Related]
89. [Image of the month: rash of H1N1 influenza].
Piérard GE
Rev Med Liege; 2012 Dec; 67(12):612-3. PubMed ID: 23342869
[No Abstract] [Full Text] [Related]
90. [Inhibition of NK cytotoxic effect mediated by influenza A virus H1N1 and the insight into a new concept of therapeutic strategy].
Su L; Liu LH
Bing Du Xue Bao; 2011 Jan; 27(1):81-5. PubMed ID: 21462512
[No Abstract] [Full Text] [Related]
91. [Influenza virus infection in progressing atherosclerosis].
Gurevich VS; Pleskov VM; Levaia MV; Bannikov AI; Mitrofanova LB; Urazgil'deeva SA
Kardiologiia; 2002; 42(7):21-4. PubMed ID: 12494108
[TBL] [Abstract][Full Text] [Related]
92. Preliminary evaluation of two rapid antigen assays for novel influenza A (H1N1) virus detection in clinical specimens.
Lévêque N; Coste JF; Renois F; Brodard V; De Champs C; Andréoletti L
J Med Microbiol; 2010 Apr; 59(Pt 4):508-509. PubMed ID: 20075112
[No Abstract] [Full Text] [Related]
93. Impact of RNA degradation on influenza diagnosis in the surveillance system.
Bai H; Zhao J; Ma C; Wei H; Li X; Fang Q; Yang P; Wang Q; Wang D; Xin L
Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115388. PubMed ID: 34030102
[TBL] [Abstract][Full Text] [Related]
94. Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1.
Durkin ML; Marchese D; Robinson MD; Ramgopal M
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24081593
[TBL] [Abstract][Full Text] [Related]
95. 1918 H1N1 Influenza Virus Infection-Induced Proinflammatory Cytokines in the Olfactory Bulb Could Trigger Lethargic Disease.
Mori I
J Infect Dis; 2018 Oct; 218(10):1686-1687. PubMed ID: 30184149
[No Abstract] [Full Text] [Related]
96. The role of oxidative stress in influenza virus infection.
Liu M; Chen F; Liu T; Chen F; Liu S; Yang J
Microbes Infect; 2017 Dec; 19(12):580-586. PubMed ID: 28918004
[TBL] [Abstract][Full Text] [Related]
97. OLYMPUS: an automated hybrid clustering method in time series gene expression. Case study: host response after Influenza A (H1N1) infection.
Dimitrakopoulou K; Vrahatis AG; Wilk E; Tsakalidis AK; Bezerianos A
Comput Methods Programs Biomed; 2013 Sep; 111(3):650-61. PubMed ID: 23796450
[TBL] [Abstract][Full Text] [Related]
98. H1N1-related SIRS?
McAlister VC
CMAJ; 2009 Oct; 181(9):616-7. PubMed ID: 19858268
[No Abstract] [Full Text] [Related]
99. A simple and powerful method for the estimation of intervention effects on serological endpoints using paired interval-censored data.
Xu Y; Lam KF; Ooi EE; Wilder-Smith A; Paton NI; Lee LS; Cheung YB
J Biopharm Stat; 2015; 25(1):124-36. PubMed ID: 24835750
[TBL] [Abstract][Full Text] [Related]
100. The passive strategy: increasing the force in the battle against influenza.
Grabherr R
Biotechnol J; 2014 Dec; 9(12):1476-7. PubMed ID: 25104227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
